Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism GJA1 inhibitors(Gap junction alpha-1 protein inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic macular oedema | Preclinical | US | - | |
Dystrophy, Macular | Preclinical | US | - |